New Jersey
|
001-31990
|
22-1441806
|
(State or other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
TEL-INSTRUMENT ELECTRONICS CORP.
|
|||
Date: November 17, 2015
|
By:
|
/s/ Joseph P. Macaluso
|
|
Name: Joseph P. Macaluso
|
|||
Title: Principal Accounting Officer
|
|
·
|
Revenues increased to $6.8 million, a 90% increase versus the comparable period of fiscal year 2015.
|
|
·
|
Operating income increased to $916k, a $1.2 million improvement versus second quarter of 2015.
|
|
·
|
Strong operating cash flow and significant improvement in cash balances.
|
|
·
|
Interest expense dropped 55% over the comparable period of the previous year due to new bank deal and lower balances.
|
|
·
|
Non-GAAP EBITDA of $964,465 or $0.30 per share.
|
|
Ø
|
Tax accrual included in our GAAP accounting is a non-cash item due to Tel’s large tax NOL.
|
|
·
|
$519k warrant valuation increase due to trailing 12 months EBITDA doubling to over $2.4 million.
|
|
·
|
GAAP earnings per share of $0.06 per share, versus a loss of $0.08 per share in the comparable period of the previous year.
|
Contact: | Joseph P. Macaluso | John Nesbett or Jennifer Belodeau |
Tel-Instrument Electronics Corp. | Institutional Marketing Services (IMS) | |
(201) 933-1600 | (203) 972-9200 | |
jnesbett@institutionalms.com |
September 30,
2015
|
March 31,
2015
|
|||||||
(unaudited)
|
||||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
795,393
|
$
|
185,932
|
||||
Accounts receivable, net
|
860,856
|
1,625,171
|
||||||
Inventories, net
|
4,686,063
|
4,032,074
|
||||||
Prepaid expenses and other current assets
|
376,568
|
281,002
|
||||||
Deferred financing costs
|
5,429
|
5,429
|
||||||
Deferred income tax asset
|
1,064,395
|
1,064,395
|
||||||
Total current assets
|
7,788,704
|
7,194,003
|
||||||
Equipment and leasehold improvements, net
|
224,192
|
270,792
|
||||||
Deferred financing costs – long-term
|
6,077
|
8,792
|
||||||
Deferred income tax asset – non-current
|
1,991,718
|
2,377,583
|
||||||
Other long-term assets
|
33,509
|
32,317
|
||||||
Total assets
|
10,044,200
|
9,883,487
|
||||||
LIABILITIES & STOCKHOLDERS’ EQUITY
|
||||||||
Current liabilities:
|
||||||||
Current portion of long-term debt, net of debt discount
|
405,718
|
387,839
|
||||||
Capital lease obligations – current portion
|
13,231
|
16,758
|
||||||
Accounts payable and accrued liabilities
|
3,022,230
|
3,577,566
|
||||||
Deferred revenues – current portion
|
15,483
|
18,609
|
||||||
Accrued payroll, vacation pay and payroll taxes
|
689,904
|
594,114
|
||||||
Total current liabilities
|
4,146,566
|
4,594,886
|
||||||
Subordinated notes payable - related parties
|
125,000
|
250,000
|
||||||
Capital lease obligations – long-term
|
-
|
4,561
|
||||||
Long-term debt
|
516,977
|
708,604
|
||||||
Deferred revenues – long-term
|
132,068
|
133,650
|
||||||
Warrant liability
|
969,790
|
518,962
|
||||||
Other long-term liabilities
|
20,400
|
33,000
|
||||||
Total liabilities
|
5,910,801
|
6,243,663
|
||||||
Commitments
|
||||||||
Stockholders' equity:
|
||||||||
Common stock, 4,000,000 shares authorized, par value $0.10 per share,
3,256,887 and 3,256,887 shares issued and outstanding, respectively
|
325,686
|
325,686
|
||||||
Additional paid-in capital
|
8,061,211
|
8,046,168
|
||||||
Accumulated deficit
|
(4,253,498
|
)
|
(4,732,030
|
)
|
||||
Total stockholders' equity
|
4,133,399
|
3,639,824
|
||||||
Total liabilities and stockholders' equity
|
$
|
10,044,200
|
$
|
9,883,487
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
September 30,
2015
|
September 30,
2014
|
September 30,
2015
|
September 30,
2014
|
|||||||||||||
Net sales
|
$
|
6,818,390
|
$
|
3,587,674
|
$
|
12,664,309
|
$
|
6,716,750
|
||||||||
Cost of sales
|
4,574,924
|
2,718,330
|
8,605,548
|
4,727,189
|
||||||||||||
Gross margin
|
2,243,466
|
869,344
|
4,058,761
|
1,989,561
|
||||||||||||
Operating expenses:
|
||||||||||||||||
Selling, general and administrative
|
883,876
|
660,034
|
1,749,564
|
1,539,227
|
||||||||||||
Engineering, research and development
|
443,656
|
497,726
|
935,788
|
981,622
|
||||||||||||
Total operating expenses
|
1,327,532
|
1,157,760
|
2,685,352
|
2,520,849
|
||||||||||||
Income (loss) from operations
|
915,934
|
(288,416
|
)
|
1,373,409
|
(531,288
|
)
|
||||||||||
Other income (expense):
|
||||||||||||||||
Amortization of debt discount
|
-
|
(30,061
|
)
|
-
|
(60,935
|
)
|
||||||||||
Amortization of deferred financing costs
|
(1,358
|
)
|
(27,080
|
)
|
(2,715
|
)
|
(54,160
|
)
|
||||||||
Change in fair value of common stock warrants
|
(518,588
|
)
|
27,801
|
(450,828
|
)
|
(106,080
|
)
|
|||||||||
Interest expense
|
(25,835
|
)
|
(57,387
|
)
|
(55,469
|
)
|
(119,867
|
)
|
||||||||
Total other expense
|
(545,781
|
)
|
(86,727
|
)
|
(509,012
|
)
|
(341,042
|
)
|
||||||||
Income (loss) before income taxes
|
370,153
|
(375,143
|
)
|
864,397
|
(872,330
|
)
|
||||||||||
Income tax expense (benefit)
|
170,687
|
(126,948
|
)
|
385,865
|
(240,130
|
)
|
||||||||||
Net income (loss)
|
$
|
199,466
|
$
|
(248,195
|
)
|
$
|
478,532
|
$
|
(632,200
|
)
|
||||||
Basic income (loss) per common share
|
$
|
0.06
|
$
|
(0.08
|
)
|
$
|
0.15
|
$
|
(0.19
|
)
|
||||||
Diluted income (loss) per common share
|
$
|
0.06
|
$
|
(0.08
|
)
|
$
|
0.15
|
$
|
(0.19
|
)
|
||||||
Weighted average shares outstanding:
|
||||||||||||||||
Basic
|
3,256,887
|
3,252,702
|
3,256,887
|
3,252,048
|
||||||||||||
Diluted
|
3,260,799
|
3,252,702
|
3,262,058
|
3,252,048
|
Three Months
|
Three Months
|
|||||||
Ended
|
Ended
|
|||||||
September 30,
|
September 30,
|
|||||||
2015
|
2014
|
|||||||
Net income (loss)
|
$ | 199,466 | $ | (248,195 | ) | |||
Income tax provision (benefit)
|
170,687 | (126,948 | ) | |||||
Depreciation and amortization
|
39,958 | 44,728 | ||||||
Amortization of debt discount
|
- | 30,061 | ||||||
Amortization of deferred financing costs
|
1,358 | 27,080 | ||||||
Change on fair value of common stock warrants
|
518,588 | (27,801 | ) | |||||
Interest, net
|
25,835 | 57,387 | ||||||
Non-cash stock-based compensation
|
8,577 | 8,841 | ||||||
Non-GAAP EBITDA
|
$ | 964,465 | $ | (234,847 | ) | |||
Non-GAAP EBITDA per common share
|
$ | 0.30 | $ | (0.07 | ) | |||
Basic weighted average shares outstanding
|
3,256,887 | 3,252,702 |